AI assistant
PRECISION BIOSCIENCES INC — Director's Dealing 2023
Mar 7, 2023
34491_dirs_2023-03-07_12e87e17-6576-4959-9d33-ff953e237c99.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2023-02-28
Reporting Person: Scimeca Dario (General Counsel and Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-28 | Common Stock | A | 2163 | $0.95 | Acquired | 34677 | Direct |
| 2023-03-03 | Common Stock | M | 27558 | — | Acquired | 62235 | Direct |
| 2023-03-06 | Common Stock | S | 12172 | $1.07 | Disposed | 50063 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-03 | Restricted Stock Units | $ | M | 27558 | Disposed | Common Stock (27558) | Direct |
Footnotes
F1: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023.
F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
F4: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.